Author:
Hubble Jean,Koller William C.,Atchison Paul,Taylor Anne C.,Citerone David R.,Zussman Barry D.,Friedman Carl J.,Hawker Noele
Subject
Pharmacology (medical),Pharmacology
Reference9 articles.
1. Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist;Eden;Pharmacol Biochem Behav,1991
2. Ropinirole for the treatment of early Parkinson's disease;Adler;Neurology,1997
3. A 3-year randomized trials of ropinirole and bromocriptine in early Parkinson's disease;Korczyn;Neurology,1999
4. Reduced risk of dyskinesia with ropinirole in early Parkinson's disease (PD). Fourth Congress of the European Federation of Neurological Societies, Lisbon, Portugal, Sep 7-11, 1999;Rascol O, on behalf of the 056 Study Group.;Eur J Neurol,1999
5. A multicenter, double-blind, placebo-controlled trial of ropinirole as an adjunct to L-dopa in the treatment of Parkinson's disease patients with motor fluctuations;Lieberman;Neurology,1998
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献